drugset / Trial / NCT02481583

Pharmacokinetic Study of Levosulpiride

NCT02481583

RandomizedParallel-groupOpen-labelBasic science

Summary

The aim of this study was to characterise the pharmacokinetic properties and assess the safety of different formulations of levosulpiride in healthy Chinese volunteers.

Timeline

Start
2013-03
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Levosulpiride Small molecule 25 mg Oral
Subject Levosulpiride Small molecule 50 mg Oral
Subject Levosulpiride Small molecule 75 mg Oral
Subject Levosulpiride Small molecule 100 mg Oral

Indications